WallStreetZenWallStreetZen

NASDAQ: TMCI
Treace Medical Concepts Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TMCI

Based on 4 analysts offering 12 month price targets for Treace Medical Concepts Inc

Min Forecast
$3.00+2.74%
Avg Forecast
$4.96+69.97%
Max Forecast
$6.00+105.48%

Should I buy or sell TMCI stock?

Based on 4 analysts offering ratings for Treace Medical Concepts Inc.

Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
3 analysts 75%
Sell
0 analysts 0%
Strong Sell
1 analysts 25%
Although TMCI's forecast from analysts indicates a "Sell", our proven Zen Rating quant model rates TMCI as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their TMCI stock forecasts and price targets.

TMCI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-18
lockedlocked$00.00+00.00%2025-11-07
lockedlocked$00.00+00.00%2025-11-07
lockedlocked$00.00+00.00%2025-08-08

1 of 1

Forecast return on equity

Is TMCI forecast to generate an efficient return?

Company
-60.19%
Industry
20.72%
Market
341.97%
TMCI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TMCI forecast to generate an efficient return on assets?

Company
-27.31%
Industry
11.68%
TMCI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TMCI earnings per share forecast

What is TMCI's earnings per share in the next 2 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$0.87
Avg 2 year Forecast
-$0.84

TMCI revenue forecast

What is TMCI's revenue in the next 2 years based on estimates from 8 analysts?

Avg 1 year Forecast
$218.3M-0.26%
Avg 2 year Forecast
$235.5M+7.57%
TMCI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TMCI revenue growth forecast

How is TMCI forecast to perform vs Medical Devices companies and vs the US market?

Company
-0.26%
Industry
12.54%
Market
1,474.34%
TMCI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TMCI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TMCI vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
TMCI$2.92$4.96+69.97%Sell
INGN$6.79N/AN/A
MASS$5.40$12.00+122.22%Buy
NNOX$3.03$8.00+164.03%Strong Buy
CVRX$7.92$12.00+51.52%Strong Buy
View Top Medical Device Stocks

Treace Medical Concepts Stock Forecast FAQ

Is Treace Medical Concepts Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: TMCI) stock is to Sell TMCI stock.

Out of 4 analysts, 0 (0%) are recommending TMCI as a Strong Buy, 0 (0%) are recommending TMCI as a Buy, 3 (75%) are recommending TMCI as a Hold, 0 (0%) are recommending TMCI as a Sell, and 1 (25%) are recommending TMCI as a Strong Sell.

If you're new to stock investing, here's how to buy Treace Medical Concepts stock.

What is TMCI's earnings growth forecast for 2026-2027?

(NASDAQ: TMCI) Treace Medical Concepts's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 39.53%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,164.25%.

Treace Medical Concepts's earnings in 2026 is -$50,109,000.On average, 8 Wall Street analysts forecast TMCI's earnings for 2026 to be -$55,243,569, with the lowest TMCI earnings forecast at -$68,688,083, and the highest TMCI earnings forecast at -$45,494,704.

In 2027, TMCI is forecast to generate -$53,682,477 in earnings, with the lowest earnings forecast at -$74,932,454 and the highest earnings forecast at -$38,804,306.

What is TMCI's revenue growth forecast for 2026-2027?

(NASDAQ: TMCI) Treace Medical Concepts's forecast annual revenue growth rate of -0.26% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,474.34%.

Treace Medical Concepts's revenue in 2026 is $218,879,000.On average, 8 Wall Street analysts forecast TMCI's revenue for 2026 to be $13,910,292,517, with the lowest TMCI revenue forecast at $12,800,960,866, and the highest TMCI revenue forecast at $15,180,830,892.

In 2027, TMCI is forecast to generate $15,002,420,288 in revenue, with the lowest revenue forecast at $13,425,397,981 and the highest revenue forecast at $17,006,990,864.

What is TMCI's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: TMCI) forecast ROA is -27.31%, which is lower than the forecast US Medical Devices industry average of 11.68%.

What is TMCI's Price Target?

According to 4 Wall Street analysts that have issued a 1 year TMCI price target, the average TMCI price target is $4.96, with the highest TMCI stock price forecast at $6.00 and the lowest TMCI stock price forecast at $3.00.

On average, Wall Street analysts predict that Treace Medical Concepts's share price could reach $4.96 by Dec 18, 2026. The average Treace Medical Concepts stock price prediction forecasts a potential upside of 69.97% from the current TMCI share price of $2.92.

What is TMCI's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: TMCI) Treace Medical Concepts's current Earnings Per Share (EPS) is -$0.80. On average, analysts forecast that TMCI's EPS will be -$0.87 for 2026, with the lowest EPS forecast at -$1.08, and the highest EPS forecast at -$0.71. In 2027, TMCI's EPS is forecast to hit -$0.84 (min: -$1.18, max: -$0.61).

What is TMCI's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: TMCI) forecast ROE is -60.19%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.